Literature DB >> 16213085

TRPV4 mediates pain-related behavior induced by mild hypertonic stimuli in the presence of inflammatory mediator.

Nicole Alessandri-Haber1, Elizabeth Joseph, Olayinka A Dina, Wolfgang Liedtke, Jon D Levine.   

Abstract

The ligand-gated ion channel, TRPV4, functions as a transducer of hypotonic stimuli in primary afferent nociceptive neurons and contributes to inflammatory and neuropathic pain. Hypertonic saline also stimulates primary afferent nociceptors and the injection of mild hypertonic saline (2-5%) is widely used as an experimental model of pain in humans. Therefore, we tested whether TRPV4 participates in the transduction of hypertonic stimuli. Intradermal injection of 2% (607 mOsm) or 10% (3,250 mOsm) saline solution in the hind paw of rats induced a concentration-dependent pain-related behavior, flinching. Sensitization with prostaglandin E(2) (PGE(2)) caused a 7-fold increase in the number of flinches induced by 2% saline but failed to increase those caused by 10% saline. Spinal administration of antisense oligodeoxynucleotides to TRPV4 caused a 46% decrease in the number of flinches induced by 2% saline, but there was no change in flinching induced by 10% saline. Similarly, only the nociceptive behavior caused by 2% saline was reduced in TRPV4(-/-) knockout mice. The TRPV4-mediated nociceptive behaviors induced by hyper- and hypotonic stimuli were dependent on Src tyrosine kinase. We suggest TRPV4 is a transducer in primary afferents that mediates nociceptive behavior induced by small increases or decreases in osmolarity. Such changes in osmolarity might contribute to pain in inflammatory and neuropathic states.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16213085     DOI: 10.1016/j.pain.2005.07.016

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  81 in total

1.  The ΔC splice-variant of TRPM2 is the hypertonicity-induced cation channel in HeLa cells, and the ecto-enzyme CD38 mediates its activation.

Authors:  Tomohiro Numata; Kaori Sato; Jens Christmann; Romy Marx; Yasuo Mori; Yasunobu Okada; Frank Wehner
Journal:  J Physiol       Date:  2012-01-04       Impact factor: 5.182

2.  A TRP that makes us feel hyper.

Authors:  Charles W Bourque; Farshid Guilak; Wolfgang Liedtke
Journal:  J Physiol       Date:  2012-04-15       Impact factor: 5.182

Review 3.  Nociceptors: the sensors of the pain pathway.

Authors:  Adrienne E Dubin; Ardem Patapoutian
Journal:  J Clin Invest       Date:  2010-11-01       Impact factor: 14.808

4.  Resolvin D1 attenuates activation of sensory transient receptor potential channels leading to multiple anti-nociception.

Authors:  S Bang; S Yoo; T J Yang; H Cho; Y G Kim; S W Hwang
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

5.  Nociceptive and pro-inflammatory effects of dimethylallyl pyrophosphate via TRPV4 activation.

Authors:  S Bang; S Yoo; T J Yang; H Cho; S W Hwang
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

Review 6.  TRPs and pain.

Authors:  Yi Dai
Journal:  Semin Immunopathol       Date:  2015-09-15       Impact factor: 9.623

Review 7.  New insights into protease-activated receptor 4 signaling pathways in the pathogenesis of inflammation and neuropathic pain: a literature review.

Authors:  Yanju Bao; Yebo Gao; Liping Yang; Xiangying Kong; Honggang Zheng; Wei Hou; Baojin Hua
Journal:  Channels (Austin)       Date:  2015       Impact factor: 2.581

8.  The modulation of voltage-gated potassium channels by anisotonicity in trigeminal ganglion neurons.

Authors:  L Chen; C Liu; L Liu
Journal:  Neuroscience       Date:  2008-03-29       Impact factor: 3.590

9.  A TRPV4 channel C-terminal folding recognition domain critical for trafficking and function.

Authors:  Lei Lei; Xu Cao; Fan Yang; Di-Jing Shi; Yi-Quan Tang; Jie Zheng; KeWei Wang
Journal:  J Biol Chem       Date:  2013-03-02       Impact factor: 5.157

10.  Osmolality-induced tuning of action potentials in trigeminal ganglion neurons.

Authors:  Lei Chen; Changjin Liu; Lieju Liu
Journal:  Neurosci Lett       Date:  2009-03-06       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.